Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
0.500 Biomarker group BEFREE The effect of psychosis associated CACNA1C, and its epistasis with ZNF804A, on brain function. 30079586 2019
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
0.500 GeneticVariation group BEFREE This included an association between the rs2007044 (risk allele G) within CACNA1C and poorer working memory performance (increased errors B (95% CI)=0.635-4.535, p=0.012), an effect driven mainly by the psychosis groups. 28607492 2017
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
0.500 GeneticVariation group BEFREE Our data suggests a minor involvement of CACNA1C rs1006737 in psychosis via conferring susceptibility to white matter microstructural abnormalities in SZ. 27790829 2017
Entrez Id: 203228
Gene Symbol: C9orf72
C9orf72
0.500 GeneticVariation group BEFREE The pathogenic repeat expansion [GGGGCC]<sub>n</sub> found at the C9orf72 locus is the most common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), and has also been documented in patients with psychosis and schizophrenia. 28320191 2017
Entrez Id: 203228
Gene Symbol: C9orf72
C9orf72
0.500 GeneticVariation group BEFREE Thalamus degeneration was identified only in bvFTD cases with the C9ORF72 repeat expansion, and to a similar extent in cases with and without psychosis. 28482638 2017
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
0.500 Biomarker group BEFREE Further study of CACNA1C using intermediate phenotypes for psychosis will determine the mechanisms by which variation in this gene confers risk. 26048451 2016
Entrez Id: 203228
Gene Symbol: C9orf72
C9orf72
0.500 GeneticVariation group BEFREE Despite the high frequency of psychiatric symptoms in bvFTD patients and the extremely high prevalence of the C9ORF72 expansion in Finland, pathogenic expansion (>40 repeats) was not detected among the Northern Finland Birth Cohort 1966 individuals with psychosis, indicating that these disorders, especially schizophrenia before the age of 43 years, may not be associated with the C9ORF72 expansion. 26862832 2016
Entrez Id: 203228
Gene Symbol: C9orf72
C9orf72
0.500 GeneticVariation group BEFREE Among participants in a genetic study of psychoses (N=739), two pairs of related individuals had C9orf72 expansions, of whom three were diagnosed with schizophrenia (SZ) / schizoaffective disorder (SZA), but their clinical features did not suggest dementia or ALS. 26723138 2016
Entrez Id: 203228
Gene Symbol: C9orf72
C9orf72
0.500 Biomarker group BEFREE In our study, we aimed to screen patients affected by atypical parkinsonian syndromes or PD complicated by psychosis or dementia for the presence of C9ORF72 repeat expansions, and in unrelated age- and sex-matched healthy controls. 26275564 2015
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
0.500 Biomarker group PSYGENET Impaired reward processing may be a transdiagnostic phenotype of variation in CACNA1C that could contribute to anhedonia and other clinical features common to both affective and psychotic disorders. 25290268 2014
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
0.500 Biomarker group PSYGENET The CACNA1C gene, which codes for subunit alpha-1C of the Cav1.2 voltage-dependent L-type calcium channel, has been consistently found to be the shared risk gene for several kinds of mental disorder. 24262814 2014
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
0.500 Biomarker group PSYGENET Since CACNA1C variants have been associated repeatedly with psychosis at a genome-wide level, and preclinical data provide convergent evidence for the relevance of the CACNA1C gene for hippocampal and frontolimbic plasticity and adaptive regulation of stress, our data suggest a potential pathophysiological mechanism conferred by CACNA1C variants that may mediate risk for symptom dimensions shared among bipolar disorder, major depression, and schizophrenia. 24642287 2014
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
0.500 GeneticVariation group BEFREE A history of suicide attempt was assessed in a sample of 1009 patients with BD, SCZ and related psychosis spectrum disorders, and associations with the joint genetic risk variants for BD and SCZ (rs2239547 (ITIH3/4-region), rs10994359 (ANK3) and rs4765905 (CACNA1C)) were investigated. 24461634 2014
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
0.500 Biomarker group BEFREE The CACNA1C gene, which codes for subunit alpha-1C of the Cav1.2 voltage-dependent L-type calcium channel, has been consistently found to be the shared risk gene for several kinds of mental disorder. 24262814 2014
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
0.500 GeneticVariation group BEFREE Impaired reward processing may be a transdiagnostic phenotype of variation in CACNA1C that could contribute to anhedonia and other clinical features common to both affective and psychotic disorders. 25290268 2014
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
0.500 GeneticVariation group BEFREE Hippocampal and frontolimbic function as intermediate phenotype for psychosis: evidence from healthy relatives and a common risk variant in CACNA1C. 24411473 2014
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
0.500 GeneticVariation group GWASDB Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. 24280982 2014
Entrez Id: 203228
Gene Symbol: C9orf72
C9orf72
0.500 Biomarker group BEFREE Here, we genotyped the repeat at C9ORF72 in a large Irish psychosis case-control sample (n = 2477).We found no carriers of >30 repeats. 24411481 2014
Entrez Id: 203228
Gene Symbol: C9orf72
C9orf72
0.500 GeneticVariation group BEFREE Results revealed: 1) prevalence is approximately 10%, 2) TDP-43 type B and FUS pathologies might have relatively high frequency of psychosis, 3) psychosis in FTD is higher with genetic mutations of C9ORF72 and GRN, 4) imaging researches did not achieve conclusive results, and 5) no treatment for psychosis in FTD is currently available. 24898651 2014
Entrez Id: 775
Gene Symbol: CACNA1C
CACNA1C
0.500 GeneticVariation group BEFREE Since CACNA1C variants have been associated repeatedly with psychosis at a genome-wide level, and preclinical data provide convergent evidence for the relevance of the CACNA1C gene for hippocampal and frontolimbic plasticity and adaptive regulation of stress, our data suggest a potential pathophysiological mechanism conferred by CACNA1C variants that may mediate risk for symptom dimensions shared among bipolar disorder, major depression, and schizophrenia. 24642287 2014
Entrez Id: 203228
Gene Symbol: C9orf72
C9orf72
0.500 GeneticVariation group BEFREE In contrast, C9ORF72-FTLD is predominantly associated with behavioural variant FTD, which often presents with psychosis, most commonly in the form of hallucinations and delusions. 24493408 2014
Entrez Id: 203228
Gene Symbol: C9orf72
C9orf72
0.500 Biomarker group PSYGENET The repeat expansion in C9ORF72 is a common cause of FTLD and often presents with late-onset psychosis or memory impairment. 23473366 2013
Entrez Id: 203228
Gene Symbol: C9orf72
C9orf72
0.500 Biomarker group PSYGENET Patients with frontotemporal lobar degeneration with the C9ORF72 repeat expansion are more likely than those without to present with psychosis. 23036583 2013
Entrez Id: 203228
Gene Symbol: C9orf72
C9orf72
0.500 Biomarker group PSYGENET Detailed histories revealed a higher prevalence of psychosis, including visual and auditory hallucinations and delusions, in the 8 C9ORF72 carriers than in our patients with sporadic FTD. 24077574 2013
Entrez Id: 203228
Gene Symbol: C9orf72
C9orf72
0.500 GeneticVariation group BEFREE Psychosis and hallucinations in frontotemporal dementia with the C9ORF72 mutation: a detailed clinical cohort. 24077574 2013